Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2020 · 10-Q
Revenue$142.59M$142.59M+14.5% vs Q2 2019 Net Income-$6.74M-$6.74MN/M vs Q2 2019 EPS Diluted-$0.23-$0.23N/M vs Q2 2019 Gross Profit$15,514,000−8.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived-$9,483,000N/M Free Cash Flowderived-$15,531,000N/M Margins · derivedGross margin10.9%−2.7 pt vs Q2 2019
Operating margin-4.2%−4.2 pt vs Q2 2019
Net margin-4.7%−4.3 pt vs Q2 2019
ended Nov 24, 2019 · filed Jan 2, 2020 · 39 d after period end